RPA1 and leishmaniasis: Since the goal of this study was to evaluate RPA quantification in clinical samples of leishmaniasis, the cut-off reporting window of the exponential phase (E-phase) was determined empirically using LD-qPCR positive (high to low Ct values) and LD-qPCR negative clinical samples.